BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Abroad (travel likely)RecruitingPHASE2
Conditions
Systemic Lupus Erythematosus · Inflammatory Myopathy · Systemic Sclerosis (SSc) · ANCA-associated Vasculitis · IgG4-Related Diseases · Antiphospholipid Syndrome · Acquired Thrombotic Thrombocytopenic Purpura · Behcet Disease · Sjogren Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing Municipality, China
Study leads
Zhanguo Li
Principal Investigator
Peking University Institute of Rheuamotology and Immunology